HCV / Hepatitis

>

Latest News

First Patient Enrolled in Phase 3 Study for Hepatitis D Treatment
First Patient Enrolled in Phase 3 Study for Hepatitis D Treatment

September 8th 2025

Bluejay Therapeutics’ investigational therapy, brelovitug, offers weekly self-administered injections and will be studied against the only approved treatment outside the US.

Top 5 Infectious Disease News Stories Week of August 16-23
Top 5 Infectious Disease News Stories Week of August 16-23

August 23rd 2025

Cumulative HBsAg/HBV DNA Ratio Predicts Disease Progression in Immune-Tolerant Hepatitis B
Cumulative HBsAg/HBV DNA Ratio Predicts Disease Progression in Immune-Tolerant Hepatitis B

August 21st 2025

Global Study Results Find Gaps in Hepatitis B Diagnosis, Treatment, and Care Cascade
Global Study Results Find Gaps in Hepatitis B Diagnosis, Treatment, and Care Cascade

August 20th 2025

Meeting Patients Where They Are: Hepatitis C Barriers in Pharmacy Practice
Meeting Patients Where They Are: Hepatitis C Barriers in Pharmacy Practice

August 13th 2025

More News

© 2025 MJH Life Sciences

All rights reserved.